Antifungal treatment

The request was successful.

Dear Aneurin Bevan University Health Board,

I would be grateful if you would please answer the following questions concerning antifungal treatment within your organisation.

1) What is the number of patients in the last 12 months treated with the following product lines:

A) anidulafungin
B) caspofungin
C) micafungin

2) What is the split of indication over the last 12 months for the following product lines:

A) anidulafungin
B) caspofungin
C) micafungin

3) For each of the indication splits of the 3 product lines mentioned previously (anidulafungin, caspofungin and micafungin from Q2) list the average length of treatment time.

Many thanks for answering these questions.
Yours Faithfully,

Yours faithfully,

BEN HOLDSWORTH

Lucy Bennett (Aneurin Bevan UHB - Corporate Services), Aneurin Bevan University Health Board

Dear Sir/Madam,
 
Thank you for your request for information under the Freedom of
Information Act received on 27^th June 2022. We have allocated it the
following reference number FOI 22-287 and will be in contact again
shortly.
 
We aim to respond to all Freedom of Information requests within 20 working
days from the date of receipt.
 
In the meantime, if we can be of any further assistance, please do not
hesitate to contact me.
Kind regards,
Shane Dunning (On behalf of)
Lucy Bennett
Rheolwr Gwasanaethau Corfforaethol - Rhyddid Gwybodaeth/Corporate Services
Manager - Freedom of Information
 
Bwrdd Iechyd Prifysgol Aneurin Bevan/Aneurin Bevan University Health Board
Ystafell 043, Pencadlys, Ysbyty Sant Cadog, Ffordd y Lodj, Caerllion,
Casnewydd, NP18 3XQ/Room 043, Headquarters, St Cadoc's Hospital, Lodge
Road, Caerleon, Newport, NP18 3XQ
E-bost/E-mail: [1][email address]
Ffôn/Tel: Extension 55956 or (01633) 435956 (external)

══════════════════════════════════════════════════════════════════════════

From: BEN HOLDSWORTH <[FOI #873599 email]>
Sent: 27 June 2022 10:55
To: ABB_FOI <[Aneurin Bevan LHB request email]>
Subject: Freedom of Information request - Antifungal treatment
 
[Some people who received this message don't often get email from
[FOI #873599 email]. Learn why this is important at
[2]https://aka.ms/LearnAboutSenderIdentific... ]

WARNING: This email originated from outside of NHS Wales. Do not open
links or attachments unless you know the content is safe.

Dear Aneurin Bevan University Health Board,

I would be grateful if you would please answer the following questions
concerning antifungal treatment within your organisation.

1)      What is the number of patients in the last 12 months treated with
the following product lines:

A)      anidulafungin
B)      caspofungin
C)       micafungin

2)      What is the split of indication over the last 12 months for the
following product lines:

A)      anidulafungin
B)      caspofungin
C)      micafungin

3)      For each of the indication splits of the 3 product lines mentioned
previously (anidulafungin, caspofungin and micafungin from Q2) list the
average length of treatment time.

Many thanks for answering these questions.
Yours Faithfully,

Yours faithfully,

BEN HOLDSWORTH

-------------------------------------------------------------------

Please use this email address for all replies to this request:
[FOI #873599 email]

Is [Aneurin Bevan LHB request email] the wrong address for Freedom of Information
requests to Aneurin Bevan University Health Board? If so, please contact
us using this form:
[3]https://scanmail.trustwave.com/?c=261&am...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[4]https://scanmail.trustwave.com/?c=261&am...

For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[5]https://scanmail.trustwave.com/?c=261&am...
[6]https://scanmail.trustwave.com/?c=261&am...

Please note that in some cases publication of requests and responses will
be delayed.

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------
Croesawn ohebiaeth yn Gymraeg ac yn Saesneg. Ni fydd gohebu yn Gymraeg yn
arwain at oedi. We welcome correspondence in Welsh and English.
Corresponding in Welsh will not lead to a delay.

References

Visible links
1. mailto:[email address]
2. https://aka.ms/LearnAboutSenderIdentific...
3. https://scanmail.trustwave.com/?c=261&am...
4. https://scanmail.trustwave.com/?c=261&am...
5. https://scanmail.trustwave.com/?c=261&am...
6. https://scanmail.trustwave.com/?c=261&am...

Lucy Bennett (Aneurin Bevan UHB - Corporate Services), Aneurin Bevan University Health Board

1 Attachment

Dear Sir/Madam

 

Thank you for your request for information under the Freedom of
Information Act, received on 27^th June 2022.

 

Please find attached the Health Board’s response to this request.

 

If you have any further queries please do not hesitate to contact me using
the details provided below.

 

Regards

 

Lucy Bennett
Rheolwr Gwasanaethau Corfforaethol - Rhyddid Gwybodaeth/Corporate Services
Manager - Freedom of Information

 

Bwrdd Iechyd Prifysgol Aneurin Bevan/Aneurin Bevan University Health Board
Ystafell 043, Pencadlys, Ysbyty Sant Cadog, Ffordd y Lodj, Caerllion,
Casnewydd, NP18 3XQ/Room 043, Headquarters, St Cadoc's Hospital, Lodge
Road, Caerleon, Newport, NP18 3XQ

E-bost/E-mail: [1][email address]
Ffôn/Tel: Extension 55956 or (01633) 435956 (external)

 

Croesawn ohebiaeth yn Gymraeg ac yn Saesneg. Ni fydd gohebu yn Gymraeg yn
arwain at oedi. We welcome correspondence in Welsh and English.
Corresponding in Welsh will not lead to a delay.

References

Visible links
1. mailto:[email address]